Trial Profile
A trial assessing effect of Ivacaftor on air trapping in adults with cystic fibrosis and G551D-CFTR mutation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Jun 2016
Price :
$35
*
At a glance
- Drugs Ivacaftor (Primary)
- Indications Cystic fibrosis
- Focus Therapeutic Use
- 22 Jun 2016 New trial record
- 18 May 2016 Results presented at the 112th International Conference of the American Thoracic Society